Effect of changing electrical parameters of electroconvulsive therapy (ECT) on outcome and its side effects in people with schizophrenia
Not Applicable
Completed
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2018/04/013121
- Lead Sponsor
- Dr Preeti Sinha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
Inclusion Criteria
1. Diagnosed with Schizophrenia according to DSM-5
2. Referred to receive Bifrontal ECT
3. Able to read and write in Kannada or English or Hindi.
4. Provides consent for study
Exclusion Criteria
1. ECT within last 3months
2. Mental retardation
3. Comorbid seizure disorders and organic brain disorders
4. Patients with neurological illness which would effect the cognitive functions and psychopathology will be excluded from the study.
5. Patients with a diagnosis of substance use disorder (except nicotine use disorder)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do 50pps and 125pps ECT pulse frequencies influence neurotransmitter systems in schizophrenia patients?
What is the comparative efficacy of 50pps vs. 125pps ECT for reducing positive symptoms in schizophrenia versus standard protocols?
Which biomarkers predict cognitive outcomes in CTRI/2018/04/013121 trial comparing 50pps and 125pps ECT in schizophrenia?
How do 50pps and 125pps ECT compare in adverse cognitive effects and management strategies for schizophrenia patients?
What is the impact of combining 50pps/125pps ECT with clozapine or aripiprazole on treatment-resistant schizophrenia outcomes?